(Q44595693)

English

The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases

scientific article published on 9 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases (English)

1 reference

Europe PubMed Central

4 December 2017

0 references

1 reference

based on heuristic

inferred from title

Giada Sebastiani

object named as

G Sebastiani

1

0 references

object named as

M Pirisi

7

0 references

author name string

L Castera

2

1 reference

Europe PubMed Central

4 December 2017

P Halfon

3

1 reference

Europe PubMed Central

4 December 2017

S Pol

4

1 reference

Europe PubMed Central

4 December 2017

A Mangia

5

1 reference

Europe PubMed Central

4 December 2017

V Di Marco

6

1 reference

Europe PubMed Central

4 December 2017

M Voiculescu

8

1 reference

Europe PubMed Central

4 December 2017

M Bourliere

9

1 reference

Europe PubMed Central

4 December 2017

A Alberti

10

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

9 October 2011

1 reference

Europe PubMed Central

4 December 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

4 December 2017

34

1 reference

Europe PubMed Central

4 December 2017

10

1 reference

Europe PubMed Central

4 December 2017

1202-1216

1 reference

Europe PubMed Central

4 December 2017

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Hepatitis C in the HIV-Infected Person

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Liver fibrosis -- from bench to bedside

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Natural history of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Diagnosis and quantitation of fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Noninvasive diagnosis of cirrhosis in chronic hepatitis C based on standard laboratory tests

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Implication of normal liver enzymes in liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Liver diseases in the elderly: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

HIV-related thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Diagnostic value of FibroTest with normal serum aminotransferases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Liver biopsy sampling in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Sources of variability in histological scoring of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Exceeding the limits of liver histology markers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04861.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2011.04861.X

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44595693&oldid=2028859111"